Tags

Tags

Displaying 1 - 10 of 66
Cover image of Investigating signaling molecules in breast cancer

Investigating signaling molecules in breast cancer

21 Mar 2012
Significant progress has been made in understanding breast tumour biology. However statistics indicate that the number of breast cancer patients and victims will continue to increase. Dr. Bentires-Alj, ERC Starting Grantee at the Friedrich Miescher…
Significant progress has been made in understanding breast tumour biology. However statistics indicate that the number of breast cancer patients and victims will continue to increase…
Significant progress has been made in understanding breast tumour biology. However statistics indicate that the number of breast cancer patients and…
Significant progress has been made in understanding breast tumour biology. However statistics indicate that the number of breast cancer patients and victims will continue to…
Significant progress has been made in understanding breast tumour biology. However statistics indicate that the number of…
Cover image of A ‘smart’ knife to fight cancer, crime and contamination

A ‘smart’ knife to fight cancer, crime and contamination

29 Nov 2013
Cancer is one of the most challenging medical issues we face. In the United Kingdom alone, there are 300,000 new cases every year – leading to almost two million surgical operations annually. Thanks to ERC funding, Dr Zoltán Takáts of Imperial…
Cancer is one of the most challenging medical issues we face. In the United Kingdom alone, there are 300,000 new cases every year – leading to almost two million surgical operations…
Cancer is one of the most challenging medical issues we face. In the United Kingdom alone, there are 300,000 new cases every year – leading to almost…
Cancer is one of the most challenging medical issues we face. In the United Kingdom alone, there are 300,000 new cases every year – leading to almost two million surgical…
Cancer is one of the most challenging medical issues we face. In the United Kingdom alone, there are 300,000 new cases every…
Cover image of Cancer in 3D: in-depth research to uncover its secrets

Cancer in 3D: in-depth research to uncover its secrets

04 Apr 2014
In 2012, 2.8 million people in the EU were diagnosed with cancer. It is the second most common cause of death in the Union – three out of 10 deaths for men, and two out of 10 deaths for women – a figure that is expected to rise due to the ageing…
In 2012, 2.8 million people in the EU were diagnosed with cancer. It is the second most common cause of death in the Union – three out of 10 deaths for men, and two out of 10 deaths…
In 2012, 2.8 million people in the EU were diagnosed with cancer. It is the second most common cause of death in the Union – three out of 10 deaths…
In 2012, 2.8 million people in the EU were diagnosed with cancer. It is the second most common cause of death in the Union – three out of 10 deaths for men, and two out of 10…
In 2012, 2.8 million people in the EU were diagnosed with cancer. It is the second most common cause of death in the Union –…

Smarter, faster, stronger drug therapies

03 Jul 2014
We are living longer and, understandably, we wish to be in better health as we age. It is estimated that by 2050 the number of people aged 65 and over will reach 16% of the global population. Medical science has an ever-growing arsenal of drugs it…
We are living longer and, understandably, we wish to be in better health as we age. It is estimated that by 2050 the number of people aged 65 and over will reach 16% of the global…
We are living longer and, understandably, we wish to be in better health as we age. It is estimated that by 2050 the number of people aged 65 and…
We are living longer and, understandably, we wish to be in better health as we age. It is estimated that by 2050 the number of people aged 65 and over will reach 16% of the…
We are living longer and, understandably, we wish to be in better health as we age. It is estimated that by 2050 the number…
Cover image of Lymphocytes versus hepatitis B virus: caught in action

Lymphocytes versus hepatitis B virus: caught in action

15 Apr 2015
For the first time ever, two ERC grantees, Prof. Luca G. Guidotti and Dr Matteo Iannacone, have observed in vivo how specific white blood cells, so-called cytotoxic T lymphocytes, identify, target and attack liver cells that are infected with the…
For the first time ever, two ERC grantees, Prof. Luca G. Guidotti and Dr Matteo Iannacone, have observed in vivo how specific white blood cells, so-called cytotoxic T lymphocytes,…
For the first time ever, two ERC grantees, Prof. Luca G. Guidotti and Dr Matteo Iannacone, have observed in vivo how specific white blood cells, so…
For the first time ever, two ERC grantees, Prof. Luca G. Guidotti and Dr Matteo Iannacone, have observed in vivo how specific white blood cells, so-called cytotoxic T…
For the first time ever, two ERC grantees, Prof. Luca G. Guidotti and Dr Matteo Iannacone, have observed in vivo how…
Cover image of Molecular tattooing for local, targeted drug-delivery

Molecular tattooing for local, targeted drug-delivery

12 Jun 2015
Dr Málnási-Csizmadia focuses on enzymes, proteins essential for body functions, and the largely unexplored intricate mechanisms underlying their activity. His recent findings could open the way to a ground-breaking development in pharmacology,…
Dr Málnási-Csizmadia focuses on enzymes, proteins essential for body functions, and the largely unexplored intricate mechanisms underlying their activity. His recent findings could…
Dr Málnási-Csizmadia focuses on enzymes, proteins essential for body functions, and the largely unexplored intricate mechanisms underlying their…
Dr Málnási-Csizmadia focuses on enzymes, proteins essential for body functions, and the largely unexplored intricate mechanisms underlying their activity. His recent findings…
Dr Málnási-Csizmadia focuses on enzymes, proteins essential for body functions, and the largely unexplored intricate…
Cover image of An early detection kit for colorectal cancer

An early detection kit for colorectal cancer

14 Jun 2015
Prevention and early detection largely determine the outcome of most cancers. Prof. Päivi Peltomäki studies how tumours arise and progress, with a view to identifying biomarkers of our susceptibility to developing cancer. With the ERC grant, the…
Prevention and early detection largely determine the outcome of most cancers. Prof. Päivi Peltomäki studies how tumours arise and progress, with a view to identifying biomarkers of our…
Prevention and early detection largely determine the outcome of most cancers. Prof. Päivi Peltomäki studies how tumours arise and progress, with a…
Prevention and early detection largely determine the outcome of most cancers. Prof. Päivi Peltomäki studies how tumours arise and progress, with a view to identifying…
Prevention and early detection largely determine the outcome of most cancers. Prof. Päivi Peltomäki studies how tumours…
Cover image of The driving forces of cell division

The driving forces of cell division

16 Jun 2015
With her ERC grant, the 5000th awarded to a leading scientist in Europe, Dr Iva Tolić wants to push forward the frontiers of knowledge on the mechanical principles of cell division.  To reach her goal, after spending several years in the USA,…
With her ERC grant, the 5000th awarded to a leading scientist in Europe, Dr Iva Tolić wants to push forward the frontiers of knowledge on the mechanical principles of cell division…
With her ERC grant, the 5000th awarded to a leading scientist in Europe, Dr Iva Tolić wants to push forward the frontiers of knowledge on the…
With her ERC grant, the 5000th awarded to a leading scientist in Europe, Dr Iva Tolić wants to push forward the frontiers of knowledge on the mechanical principles of cell…
With her ERC grant, the 5000th awarded to a leading scientist in Europe, Dr Iva Tolić wants to push forward the frontiers of…
Cover image of Researchers discover how genetic mutations rewire cancer cells

Researchers discover how genetic mutations rewire cancer cells

17 Sep 2015
An international team of researchers, led by ERC grantee Prof Rune Linding, discovered how genetic cancer mutations attack the networks controlling human cells. This knowledge is critical for the future development of personalized precision cancer…
An international team of researchers, led by ERC grantee Prof Rune Linding, discovered how genetic cancer mutations attack the networks controlling human cells. This knowledge is…
An international team of researchers, led by ERC grantee Prof Rune Linding, discovered how genetic cancer mutations attack the networks controlling…
An international team of researchers, led by ERC grantee Prof Rune Linding, discovered how genetic cancer mutations attack the networks controlling human cells. This…
An international team of researchers, led by ERC grantee Prof Rune Linding, discovered how genetic cancer mutations attack…
Cover image of Studied malaria, found cancer treatment

Studied malaria, found cancer treatment

02 Feb 2016
Malaria has always been the centre of attention for Dr Ali Salanti’s, a molecular parasitologist and an ERC grantee. With his studies, he hoped to bring new insight into pregnancy-associated malaria, to save the lives of women and their babies in…
Malaria has always been the centre of attention for Dr Ali Salanti’s, a molecular parasitologist and an ERC grantee. With his studies, he hoped to bring new insight into pregnancy…
Malaria has always been the centre of attention for Dr Ali Salanti’s, a molecular parasitologist and an ERC grantee. With his studies, he hoped to…
Malaria has always been the centre of attention for Dr Ali Salanti’s, a molecular parasitologist and an ERC grantee. With his studies, he hoped to bring new insight into…
Malaria has always been the centre of attention for Dr Ali Salanti’s, a molecular parasitologist and an ERC grantee. With…